Tilray Brands (TLRY) Change in Inventory (2017 - 2026)
Tilray Brands' (TLRY) quarterly Change in Inventory came in at -$8.0 million in Q2 2026, down 199.97% YoY from $8.0 million in Q2 2025, and down 187.67% on a QoQ basis from $9.1 million in Q1 2026.
Tilray Brands (TLRY) Change in Inventory (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Change in Inventory data on file, last reported at -$8.0 million in Q2 2026.
- Quarterly Change in Inventory fell 199.97% year-over-year to -$8.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $13.4 million (down 0.9% YoY) and the FY2026 annual result came in at $13.4 million, down 0.9% from the prior year.
- Change in Inventory retreated to -$8.0 million in Q2 2026, from $9.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $29.2 million in Q2 2022 to a low of -$8.0 million in Q2 2026.
- A 5-year average of $5.8 million and a median of $4.6 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory sank 1673.28% — and 2024, when it jumped 872.38%.
- Tracing TLRY's Change in Inventory over 5 years: stood at -$5.3 million in 2022, then rose by 4.91% to -$5.0 million in 2023, then increased by 15.2% to -$4.3 million in 2024, then jumped by 109.66% to $411000.0 in 2025, then tumbled by 2042.09% to -$8.0 million in 2026.
- The last three Change in Inventory figures came in at -$8.0 million (Q2 2026), $9.1 million (Q1 2026), and $411000.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 519.72 Mn | 285.09 Mn | 90.52 Mn | -7.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -7.98 Mn |
| May 31, 2026 | -7.98 Mn |
| Feb 28, 2026 | 9.11 Mn |
| Feb 28, 2026 | 9.11 Mn |
| Nov 30, 2025 | 411,000.00 |
| Nov 30, 2025 | 411,000.00 |
| Aug 31, 2025 | 11.91 Mn |
| Aug 31, 2025 | 11.91 Mn |
| May 31, 2025 | 7.98 Mn |
| May 31, 2025 | 7.98 Mn |
| Feb 28, 2025 | -2.55 Mn |
| Feb 28, 2025 | -2.55 Mn |
| Nov 30, 2024 | -4.26 Mn |
| Nov 30, 2024 | -4.26 Mn |
| Aug 31, 2024 | 12.38 Mn |
| Aug 31, 2024 | 12.38 Mn |
| May 31, 2024 | 10.95 Mn |
| May 31, 2024 | 10.95 Mn |
| Feb 29, 2024 | 13.30 Mn |
| Feb 29, 2024 | 13.30 Mn |